<?xml version = "1.0" encoding = "UTF-8"?>
<pepcTargets xmlns:xsi = "http://www.w3.org/2001/XMLSchema-instance" 
             xsi:noNamespaceSchemaLocation = "pepcDB-v9.1.xsd">
     
    <!-- A liberal adaptation and abbreviation of data provided by the TB Consortium   
         Please send comments to  jwest@rcsb.rutgers.edu  
      -->

    <!-- Format version identifier (i.e.  6,7,8,9,9.1), 
         the current version is 9.1
     -->
    <pepcFormatVersion>9.1</pepcFormatVersion>

    <!-- The name of site or project contributing protein production and 
         target information (e.g. MCSG, JCSG, CESG, TB, etc.)   
     -->
    <site>TB</site>

    <!--  All contact information related to this target, target collection,
          or related experimental trials is listed here and referenced later.
      -->
    <contactInfoList>
	  <contactInfo>
		<contactInfoId>c_1</contactInfoId>
		<name>TB Consortium - Database Group</name>
		<address>Room 105, MBI, Los Angeles 90095</address>
		<country>USA</country>
		<email>tbdbteam@mbi.ucla.edu</email>
		<organization>TB Structural Genomics Consortium</organization>
		<lab>Laboratory of David Eisenberg</lab>
		<role>Archiver</role>
	  </contactInfo>
          <contactInfo>
		 <contactInfoId>c_2</contactInfoId>	
                 <name>LANL-Protein Production Facility</name>
		 <address>Los Alamos, NM 87545</address>
		 <country>USA</country>
		 <email>ppteam@lanl.gov</email>
		 <organization>Los Alamos National Laboratory</organization>
		 <lab>Los Alamos National Laboratory</lab>
		 <role>Scientist</role>
	  </contactInfo>
    </contactInfoList>

    <!-- A reusable list of protocols which must include a unique identifier
         and a text section describing the protocol. The protocol identifier
         may be any simple code (e.g. 1, 2, clone1, pur_1, etc). The protocol 
         definition may also optionally include a name and a brief description.

         The protocols defined in this list are referenced in describing
         the experimental trials attempted on each target.           
      -->

    <protocolList>
	  <protocol>
                  <protocolId>pur_1 </protocolId>
                  <protocolName>Gel filtration 1</protocolName>
	          <protocolDescription>
                     Gel filtration purification by FPLC from Pharmacia.
                  </protocolDescription>
		  <protocolText>
It is an intermediate or final purification step to remove contaminants depending 
on the size difference of target and contaminants proteins.  Material lists:

1)  20mM Tris-HCl buffer (pH 8.0, containing 100mM NaCl, 10mM BME)- Solution A

 1M Tris-HCl, pH 8.0 (B136 Refrigerator): 80ml
 4M NaCl(B136 Refrigerator): 100ml
 14.3M ?-mercaptoethanol (Fisher, BP 176-100, B136 Refrigerator): 3.32ml
 H2O: 3816.7ml
 Filter with Disposable sterilization filter unit (Fisher, 09-740-3A, B136).
 Degas overnight.
 Store refrigerated.

2) 0.5M NaOH solution-Solution B

 Dissolve 40g NaOH (B137 Chemical shelf) in 1.8 liter D.W.
 Add H2O to 2000ml total volume.
 Filter with Disposable sterilization filter unit (Fisher, 09-740-3A, B136).
 Degas overnight.
 Store refrigerated.

3) Prepacked Superdex 75 column (Pharmacia, 17-1070-01, 2.6x 60cm, B137 Cold room)

 Method 1 bank 2 = Running method for protein
 Method 2 bank 2 = wash of column and equilibration
 Method 3 bank 2 = equilibration of column
 
 Procedures

1) Make sure column has been equilibrated with Solution A (use Method 3 Bank 2)
	- flow-rate 4ml/min
	- 150ml Solution A
2) Make sure that the system is connected properly.
	- Solution A is connected to pumpA (Pump P-500) and solution B is 
          connected to pump B (Pump P-500).
	- For solvent change, SOLVENT CHANGE button on the pump can be used.  

     To set the chart recorder (Rec 102, Pharmacia)
        2-1) On the right side of the chart recorder
	     The red pen records conductivity and the blue pen records UV absorbance.
	 	The range dial for red pen should be at 1.0V
	 	The range dial for blue pen should be at 0.1V
	 	Both CAL/VAR buttons should be in the up position.
	 	Both PEN buttons should be in the down position.
	 	Both ZERO buttons should be in the up position.
	 	Both ZERO SUPPER dials should be set to zero.
        2-2) On the left side of the chart recorder
		The INT button should be in the up position.
		The MM button should be in the down position (speed setting: 1mm/min).
		The REC button should be in the down(on) position.
		The SET, HOME, GRID and both FEED buttons should all be in the up 
                positions.
        2-3) Adjust the baseline to zero while the equilibration buffer is flowing.

3) To set the fraction collector (Frac-100, Pharmacia)
	Press the FRACTION SIZE button, enter ~1.2(min) and press the DO/STORE.
		- check to make sure that 1.2min gives you a collection volume of 4.5ml
		(The calibration &#194; actual collecting volume should be checked)
	Put 60 tubes in fraction collector and position the dispenser arm leaning on 
               the side of the first tube.
		(Once the target protein&#194;s peak position is identified, the 
                 collecting fraction # can be reduced depending 
                 on the previous run data)
4) To set the UV monitor (UV MII, Pharmacia)
	 Set the AU value to 0.2 or 0.5 depending on the loaded protein&#194;s 
         concentration.
5) To run the method
	- Prime syringe with sterile 3X dH2O several times
	Suck up the over 10 ml sample and get rid of all bubbles in syringe before 
           loading
	Inject 10ml sample into the injector by using a syringe and leave the 
           syringe while sample is running.
	(While injecting, make sure that the measurement tube in the super loop 
             goes up,which indicates you are loading the column!)
	Press the METHOD FILE and enter the bank number (#2).
	Press the STEP FORWARD twice and enter the method number (#1).
	Press DO (program will appear line by line)
	To view the method program, press STEP FORWARD for each line of the program.
	To change any line, press CHANGE or EDIT or DELETE, enter your changes, 
             then press DO.
	To print a program, press STEP FORWARD until the &#194;List&#194; prompt 
             appears, then enter the method number you want and press DO.
	To run the method, press EXIT, then the method number you want and press DO.

                    Ex) Bank 2 method 1
 Time          
 0.00           conc %B              0.0  (start with solution A)
 0.00            ml/min              1.5  (sets column flow rate)
 0.00            cm/min              1.0  (sets chart speed in the case of 
                                                   external control) 
 0.00             port.set           6.0  (directs flow-through to waste)
 0.00            valve.pos           1.1  (brings the column on line)
 1.00            valve.pos           1.2  (loads sample onto column)
 1.00            min/mark            5.0  (sets a mark on the chart)
51.00           port.set             6.1  (directs flow-through to fraction
                                                               collector)
241.00            port.set           6.0
401.00            prt pk	     1.10

 	After do/store button has been pushed and method is running, make an 
               initial mark with blue ink roller to indicate injection time
  	Write the following on the chart:
		- Date and time at which run was started
		- Absorbance (AU) setting for run
		- Chart speed (CS) (usually set to 2.00mm/min)
		- method used and bank used
 	Check periodically during the run to make sure everything is running 
            well (printer rolling, fractions collecting, etc&#194;)
 	Method takes about 2.5 hours to complete


Enter the following information:  
		Method and bank used:	Method 1 Bank 2	

		AU set to:			0.5			

		Chart speed set at:		2mm/min			

		Amount of protein loaded:	10/9 ml&#194;s

6) To wash and re-equilibrate the column after protein running,

	- Run the bank 2 method 2 following the procedure of step 7)

Time
0.00            conc %B             100  (start with solution B)
0.00            ml/min              4.0  
0.00            cm/min              0.5    
0.00            port.set            6.0  
0.00            valve.pos            1.2 
150.00          conc % B            100 
151.00          conc % B             0.0 (equilibrate the column 
                                             with solution 
301.0 conc % B
    
7) Collect fractions and load peak fractions onto a 10% Tris-glycine gel

		  </protocolText>
	  </protocol>
    </protocolList>



    <!-- A description of a project target including a list of trials used 
         to produce the protein and solve the structure.     
      -->
    <pepcTarget>
          <!-- Unique identifier for project target.  This can be any
               local identifier used within the project, but it must
               be unique within the project target list and consistent
               from across target list updates.  
            -->
	  <id>Rv2031c</id>

          <!-- The list of sequences related to this target.   -->
          <targetSequenceList>
                 <!--	A packet of information describing a target sequence.   
                        Sequences are described by a one-letter code sequence,
                        by type (i.e. protein, clone, subclone, etc), chemical
                        type (i.e. protein or dna) and construct type (i.e. full orf,
                        domain, fragment, etc).

                        In defining a target sequence, it is assumed that the sequence
                        will correspond most closely with the sequence of the ultimate 
                        structure determination.
                    -->
		  <targetSequence>
			 <oneLetterCode>
                            MATTLPVQRHPRSLFPEFSELFAAFPSFAGLRPTFDTRLMRLEDEMKEGRYEV
                            RAELPGVDPDKDVDIMVRDGQLTIKAERTEQKDFDGRSEFAYGSFVRTVSLPV
                            GADEDDIKATYDKGILTVSVAVSEGKPTEKHIQIRSTN
                         </oneLetterCode>
	                 <sequenceType>protein</sequenceType>
	                 <sequenceChemicalType>protein</sequenceChemicalType>
	                 <sequenceConstructType>domain</sequenceConstructType>
		  </targetSequence>
	  </targetSequenceList>

          <!-- Protein name  -->
	  <proteinName>hspX</proteinName>

          <!-- Universal resource locator/internet address related to this target.
               This can be a link to a project site containing more information 
               about this target, or some other related site address.  -->
 	  <url>
              http://www.doe-mbi.ucla.edu/TB/PUBLIC/qs/qsearch.php?dowork=Rv2031c
          </url>

          <!-- Additional text details about this target.   -->
	  <remark>A remarkably insightful comment about this target.</remark>

          <!-- Source organism scientific name following the nomenclature
               of the NCBI Taxonomy database (http://www.ncbi.nih.gov/Taxonomy). 
            -->
	  <sourceOrganism>Mycobacterium tuberculosis</sourceOrganism>

          <!-- A list of packets of information describing related information about this this 
               target including a database name and an identifier within the database.    
            -->
	  <databaseRefList>
		  <databaseRef>
			  <databaseName>TB.proteomic_information</databaseName>
			  <databaseId>367989</databaseId>
		  </databaseRef>
		  <databaseRef>
			  <databaseName>Genbank</databaseName>
			  <databaseId>189676547</databaseId>
		  </databaseRef>

	  </databaseRefList>

          <!-- A list of contacts responsible for this target identified
               by referencing the previously defined contact information list
            -->
          <contactInfoRefList>
               <contactInfoRef>
		  <contactInfoId>c_2</contactInfoId>
               </contactInfoRef>
          </contactInfoRefList>


          <!-- A list of protein production trials attempted for this target.  This should
               include both successful and failed trials.   

               Each trial consists of a description of a set of the sequence tasks employed 
               to produce this target. A trial includes: lab, date, contact information, 
               experimental sequence data, process status data, and references to the 
               protocols used in the trial. 
            -->
          <trialList>

		  <trial>
 
                          <!-- Date on which this trial information was updated - yyyy-mm-dd.  -->
			  <date>2001-02-14</date>

                          <!-- A list of contacts responsible for this trial identified
                               by referencing the previously defined contact information list  
                            -->
                          <contactInfoRefList>
                             <contactInfoRef>
		                   <contactInfoId>c_2</contactInfoId>
                             </contactInfoRef>
                          </contactInfoRefList>

                          <!-- The currrent status of this trial.  This should correspond to the 
                               last status recorded in the status history list 
                            -->
	                  <status>purified</status>

                          <!-- List of timestamped codes describing critical changes in target status.
                               The status history record includes laboratory name 
                               responsible for this trial, an enumerated status state,
                               the date corresponding to the beginning of this status state,
                               and an optional completion date and remark.			 
			    -->
			  <statusHistoryList>
				   <statusHistory>
		                          <lab>Los Alamos National Laboratory</lab>
					  <status>selected</status> 
					  <date>2001-01-10</date>
				   </statusHistory>
				   <statusHistory>
                                          <lab>Los Alamos National Laboratory</lab>
					  <status>cloned</status> 
					  <date>2001-02-14</date>
				   </statusHistory>
				   <statusHistory>
                                          <lab>Los Alamos National Laboratory</lab>
					  <status>expressed</status> 
					  <date>2001-02-16</date>
				   </statusHistory>
				   <statusHistory>
                                          <lab>Los Alamos National Laboratory</lab>
					  <status>soluble</status>
					  <date>2001-02-24</date>
				   </statusHistory>
				   <statusHistory>
                                           <lab>Los Alamos National Laboratory</lab>
					  <status>purified</status> 
					  <date>2001-03-01</date>
				   </statusHistory>
			  </statusHistoryList>



                          <!-- The list of experimental sequences related to this trial.  
                               These may contain deliberate modifications or unanticipated 
                               differences from the parent target protein sequence.   
                            -->
                          <trialSequenceList>

	   	            <trialSequence>
			        <oneLetterCode>
                                 MATTLPPQRHPRSLFPEFSELFAAFPSFAGLRPTFDTRLMRLEDEMKEGRYEV
                                 RAELPGVDPDKDVDIMVRDGQLTIKAERTEQKDFDGRSEFAYGSFVRTVSLPV
                                 GADEDDIKATYDKGILTVSVAVSEGKPTEKHIQ
                                </oneLetterCode>
	                        <sequenceModifications>valine 7 replaced by proline</sequenceModifications>
                                <sequenceDetails>five terminal residues cleaved</sequenceDetails>
    		                </trialSequence>
	                  </trialSequenceList>

                          <!--  A list of references to protocols defined in the protocol 
                                list that describe the tasks applied in this experimental trial.  

                                Each protocol refers to a predefined protocol description 
                                and can be accompanied by a type and optional additional details or 
                                customization.   Protocols are referenced by their protocolId 
                                as previously defined in the protocol list.  
                            -->

			  <trialProtocolList>
				   <protocolRef>
					  <protocolId>pur_1</protocolId>
                                          <protocolType>purification</protocolType>
					  <protocolDetails>
                                             A cat wisker was added for good luck.
                                          </protocolDetails>
				   </protocolRef>
			  </trialProtocolList>
		  </trial>
           </trialList>
    </pepcTarget>
</pepcTargets>